SEC Form D · filed June 5, 2023
ADIAL PHARMACEUTICALS, INC
Location
CHARLOTTESVILLE, VA
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Kevin W. Schuyler, Cfa · Charlottesville, VADirectorJames K. Anderson · Charlottesville, VADirectorWilliam B. Stilley, Iii · Charlottesville, VAExec · DirectorJoseph M. Truluck · Charlottesville, VAExecRobertson H. Gilliland · Charlottesville, VADirectorTony W. Goodman · Charlottesville, VADirectorBankole A. Johnson · Charlottesville, VAExecJames W. Newman, Jr · Charlottesville, VADirectorCary J. Claiborne · Charlottesville, VAExec · DirectorRonald Heffernan · Sandy, UTExec · DirectorPeter Feld · New York, NYDirectorJason Bergsman · Playa Vista, CAExecJesse S. Jacobs · Playa Vista, CADirectorKweli Washington · New York, NYDirectorElaine Ellingham · Toronto, Ontario, CanadaExec · DirectorMike Kerns · Playa Vista, CADirectorSever Totia · New York, NYDirectorW. C. Mccollum · Los Angeles, CAExecUrsula Newman · London, United KingdomExecThomas Scriven · Golden, CODirectorMatthew Davis · Purcellville, VADirectorFred Ausubel · Allston, MAExecCory Brown · Nashville, TNDirectorLauren Smith · Nashville, TNDirectorKiran N. Bhatraju · Shepherdstown, WVDirectorMatthew Tomich · New York, NYExec · DirectorLee Hower · Boston, MAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗